Core Scientific's largest shareholder opposes the all-stock sale to CoreWeave, stating that the transaction undervalues the company.
By: theblockbeats.news|2025/08/08 12:22:16
BlockBeats News, August 8: Core Scientific's largest shareholder, Two Seas Capital, announced that it will vote against its sale to CoreWeave in an all-stock deal, stating that the transaction was undervalued and had serious structural flaws.
In July of this year, CoreWeave announced its acquisition of the digital infrastructure company Core Scientific in an all-stock deal. The agreed-upon per-share value of this transaction is $20.40. The agreed-upon exchange ratio implies a company valuation of around $9 billion.
Kaito is launching a new round of ranking mechanism upgrades to enhance content quality and anti-cheating measures
Point of View: By 2025, Venture Capital Will Invest $25 Billion in Cryptocurrency Startups
You may also like
Share
Gainers
Latest Crypto News
12:15
A certain PIPPIN Diamond Hand chose to sell after holding the coin for over 1 year, realizing a 4066% profit.
12:15
An ICO address holding 40,000 ETH, which had been dormant for over 10 years, has awoken to deposit the ETH into staking.
11:15
Zama: Sealed-Bid Dutch Auction Token Sale to Start on January 12
11:15
Michael Saylor hints at more purchases, 100% win-rate trader predicts market going long again
10:45
Mainstream Perp DEX Overview: Hyperliquid Trading Volume Continues to Decline by 56.9% in the Last 7 Days, Lighter Trading Volume Takes a Steep Dive Ahead
Read more
Community
Customer Support:@weikecs
Business Cooperation:@weikecs
Quant Trading & MM:bd@weex.com
VIP Services:support@weex.com